Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.63 +0.04 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Operating Expenses (2014 - 2026)

Updated

Rocket Pharmaceuticals (RCKT) reported Operating Expenses of $46.92 million for Q2 2026, down 34.1% from $71.15 million a year earlier and down 3.3% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Operating Expenses (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rocket Pharmaceuticals' Operating Expenses came in at $191.64 million, down 28.4% year-over-year; for FY2025, it came in at $231.75 million, down 15.2% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $273.21 million in FY2024 (+5.2%), $259.66 million in FY2023 (+15.7%), $224.34 million in FY2022 (+34.1%) and $167.25 million in FY2021 (+24.5%).
  • Five-year quarterly Operating Expenses spans a low of $42.56 million in Q1 2022 and a high of $73.71 million in Q2 2024.
  • Year over year, Operating Expenses has now declined in each of the last seven quarters, with an average decline of 14.5% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q3 2021 (growth of 81.3%); the low point was Q2 2026 (a decline of 34.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $48.51 million (Q1 2026), $43.96 million (Q4 2025) and $52.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Rocket Pharmaceuticals 288.09 Mn 288.09 Mn - 46.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.92 Mn
Mar 31, 2026 48.51 Mn
Dec 31, 2025 43.96 Mn
Sep 30, 2025 52.25 Mn
Jun 30, 2025 71.15 Mn
Mar 31, 2025 64.39 Mn
Dec 31, 2024 62.69 Mn
Sep 30, 2024 69.42 Mn
Jun 30, 2024 73.71 Mn
Mar 31, 2024 67.38 Mn
Dec 31, 2023 63.28 Mn
Sep 30, 2023 65.43 Mn
Jun 30, 2023 68.76 Mn
Mar 31, 2023 62.19 Mn
Dec 31, 2022 69.08 Mn
Sep 30, 2022 58.49 Mn
Jun 30, 2022 54.21 Mn
Mar 31, 2022 42.56 Mn
Dec 31, 2021 44.33 Mn
Sep 30, 2021 49.65 Mn
API Access

Rocket Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY